Tag: Cancer: Lung
ASCO: Novel Meds Show Promise in Advanced NSCLC
Results presented from two phase III trials
ATS: Cancer-Related Suicide Risk Highest for Lung Cancer Patients
Odds up four-fold compared to people in the general population
Filtered Cigarettes May Up Rates of Lung Adenocarcinoma
Design of cigarette filters with ventilation implicated in rising rates
Adding Selumetinib to Docetaxel Doesn’t Up PFS in NSCLC
No improvement in progression-free survival for previously treated advanced KRAS-mutant NSCLC
Blood-Based Genome Testing Feasible for Rapid Mutation Assay
Mutation results available within 72 hours for 94 percent of non-small-cell lung CA samples evaluated
Chromosome Instability Test Prognostic in NSCLC
Chromosome instability associated with higher risk of relapse, death within 2 years
AACR: Five-Year Survival 16 Percent With Nivolumab in NSCLC
Of the 16 patients who survived at least five years, nine were male, 12 were current smokers at baseline
Raised CTCs Precede Recurrence in Locally-Advanced NSCLC
Fifteen of 20 patients with recurrence had increase in circulating tumor cell counts post chemoradiation
Counseling Visit Helps Patients Decide About Lung CA Screening
Improves patient knowledge of eligibility criteria, benefits, harms of screening with low-dose CT
Pravastatin Does Not Improve Survival in Small-Cell Lung Cancer
Median overall survival of 10.6 versus 10.7 months for pravastatin versus placebo added to chemo
